Delta to pay $8.1 million over False Claims Act violations tied to pandemic aid
By 
Oscar Gonzalez2025-07-16T20:11:00
Delta Air Lines agreed to pay $8.1 million over allegations it violated the False Claims Act by exceeding employee compensation limits it agreed to when taking federal pandemic aid money.
The U.S. Department of Justice (DOJ) announced the settlement in a press release Tuesday. The violation stems from Delta awarding compensation to corporate officers and employees that exceeded limits the company agreed to as part of the Department of the Treasury’s Payroll Support Program (PSP).
Related articles
-
ArticleNew York lab CEO allegedly billed insurers for $500M in fraudulent COVID test claims
The U.S. Department of Justice says the chief executive and medical director of Fast Lab Technologies allegedly engaged in a $500 million fraud scheme involving COVID-19 tests.
-
ArticleFlorida telecomm and CEO pay $128M for alleged scheme to defraud FCC
A Florida wireless company and its chief executive officer will pay more than $128 million to settle civil and criminal allegations that they defrauded a federal low-income telecommunications program, according to the Department of Justice.
-
Basic PageFCA enforcement rising across sectors, experts say
Federal agencies, including the Department of Justice (DOJ) and Customs and Border Protection, are expected to significantly alter the enforcement scope of the False Claims Act to reflect the enforcement priorities of the Trump Administration, experts speaking at Compliance Week’s Women in Compliance Summit in Austin, Texas.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”